The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma

被引：63

作者：

Garcia-Reyes, Balbina ^{[1
]}

Kretz, Anna-Laura ^{[1
]}

Ruff, Jan-Philipp ^{[1
]}

von Karstedt, Silvia ^{[2
,3
]}

Hillenbrand, Andreas ^{[1
]}

Knippschild, Uwe ^{[1
]}

Henne-Bruns, Doris ^{[1
]}

Lemke, Johannes ^{[1
]}

机构：

[1] Ulm Univ Hosp, Dept Gen & Visceral Surg, Albert Einstein Allee 23, D-89081 Ulm, Germany

[2] Univ Hosp Cologne, Dept Translat Genom, Weyertal 115b, D-50931 Cologne, Germany

[3] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2018年 / 19卷 / 10期

关键词：

pancreatic cancer; pancreatic ductal adenocarcinoma; CDK; cyclin-dependent kinase; INHIBITOR DINACICLIB MK-7965; CHRONIC LYMPHOCYTIC-LEUKEMIA; TRAIL-INDUCED APOPTOSIS; I DOSE-ESCALATION; CELL-CYCLE; PROTEIN-KINASE; S-PHASE; DNA-DAMAGE; REPLICATION STRESS; ANTITUMOR-ACTIVITY;

D O I：

10.3390/ijms19103219

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The family of cyclin-dependent kinases (CDKs) has critical functions in cell cycle regulation and controlling of transcriptional elongation. Moreover, dysregulated CDKs have been linked to cancer initiation and progression. Pharmacological CDK inhibition has recently emerged as a novel and promising approach in cancer therapy. This idea is of particular interest to combat pancreatic ductal adenocarcinoma (PDAC), a cancer entity with a dismal prognosis which is owed mainly to PDAC's resistance to conventional therapies. Here, we review the current knowledge of CDK biology, its role in cancer and the therapeutic potential to target CDKs as a novel treatment strategy for PDAC.

引用

页数：28

共 249 条

[31] A Phase II Study of Flavopiridol (Alvocidib) in Combination with Docetaxel in Refractory, Metastatic Pancreatic Cancer [J].

Carvajal, Richard D. ;

Tse, Archie ;

Shah, Manish A. ;

Lefkowitz, Robert A. ;

Gonen, Mithat ;

Gilman-Rosen, Lisa ;

Kortmansky, Jeremy ;

Kelsen, David P. ;

Schwartz, Gary K. ;

O'Reilly, Eileen M. .

PANCREATOLOGY, 2009, 9 (04) :404-409

[32] A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma [J].

Cassaday, Ryan D. ;

Goy, Andre ;

Advani, Suresh ;

Chawla, Purvi ;

Nachankar, Rajesh ;

Gandhi, Mansi ;

Gopal, Ajay K. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (07) :392-397

[33] The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms [J].

Chand, Saswati ;

O'Hayer, Kevin ;

Blanco, Fernando F. ;

Winter, Jordan M. ;

Brody, Jonathan R. .

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (03) :273-282

[34] Pancreatic cancer genomics [J].

Chang, David K. ;

Grimmond, Sean M. ;

Biankin, Andrew V. .

CURRENT OPINION IN GENETICS & DEVELOPMENT, 2014, 24 :74-81

[35] Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation [J].

Chen, HH ;

Wang, YC ;

Fann, MJ .

MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (07) :2736-2745

[36] Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia [J].

Chen, Rong ;

Wierda, William G. ;

Chubb, Sherri ;

Hawtin, Rachael E. ;

Fox, Judith A. ;

Keating, Michael J. ;

Gandhi, Varsha ;

Plunkett, William .

BLOOD, 2009, 113 (19) :4637-4645

[37] A Conserved Phosphorylation Site within the Forkhead Domain of FoxM1B Is Required for Its Activation by Cyclin-CDK1 [J].

Chen, Yi-Ju ;

Dominguez-Brauer, Carmen ;

Wang, Zebin ;

Asara, John M. ;

Costa, Robert H. ;

Tyner, Angela L. ;

Lau, Lester F. ;

Raychaudhuri, Pradip .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (44) :30695-30707

[38] Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase II [J].

Cheng, S. -W. Grace ;

Kuzyk, Michael A. ;

Moradian, Annie ;

Ichu, Taka-Aki ;

Chang, Vicky C. -D. ;

Tien, Jerry F. ;

Vollett, Sarah E. ;

Griffith, Malachi ;

Marra, Marco A. ;

Morin, Gregg B. .

MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (22) :4691-4704

[39] Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence [J].

Chicas, Agustin ;

Wang, Xiaowo ;

Zhang, Chaolin ;

McCurrach, Mile ;

Zhao, Zhen ;

Mert, Ozlem ;

Dickins, Ross A. ;

Narita, Masashi ;

Zhang, Michael ;

Lowe, Scott W. .

CANCER CELL, 2010, 17 (04) :376-387

[40] Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer [J].

Chou, Angela ;

Froio, Danielle ;

Nagrial, Adnan M. ;

Parkin, Ashleigh ;

Murphy, Kendelle J. ;

Chin, Venessa T. ;

Wohl, Dalia ;

Steinmann, Angela ;

Stark, Rhys ;

Drury, Alison ;

Walters, Stacey N. ;

Vennin, Claire ;

Burgess, Andrew ;

Pinese, Mark ;

Chantrill, Lorraine A. ;

Cowley, Mark J. ;

Molloy, Timothy J. ;

Waddell, Nicola ;

Johns, Amber ;

Grimmond, Sean M. ;

Chang, David K. ;

Biankin, Andrew V. ;

Sansom, Owen J. ;

Morton, Jennifer P. ;

Grey, Shane T. ;

Cox, Thomas R. ;

Turchini, John ;

Samra, Jaswinder ;

Clarke, Stephen J. ;

Timpson, Paul ;

Gill, Anthony J. ;

Pajic, Marina .

GUT, 2018, 67 (12) :2142-2155

← 1 2 3 4 5 6 7 8 9 10 →